Rekvina Laboratories Limited (BOM:526075)
India
· Delayed Price · Currency is INR 29.31
-0.59 (-1.97%)
At close: Mar 10, 2026
Rekvina Laboratories Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | - | 0.25 | 0.1 | 0.1 | 0 | 0.02 | Upgrade
|
| Cash & Short-Term Investments | 0.02 | 0.25 | 0.1 | 0.1 | 0 | 0.02 | Upgrade
|
| Cash Growth | -98.19% | 164.21% | -3.06% | 2563.04% | -82.48% | -80.91% | Upgrade
|
| Receivables | - | - | - | - | - | 0.07 | Upgrade
|
| Other Current Assets | - | 0.07 | - | - | - | - | Upgrade
|
| Total Current Assets | - | 0.33 | 0.1 | 0.1 | 0 | 0.09 | Upgrade
|
| Property, Plant & Equipment | - | - | - | 1.46 | 1.46 | - | Upgrade
|
| Long-Term Investments | - | - | - | 0.46 | 0.46 | 0.49 | Upgrade
|
| Other Long-Term Assets | - | - | - | - | - | 1.85 | Upgrade
|
| Total Assets | - | 0.33 | 0.1 | 2.02 | 1.92 | 2.43 | Upgrade
|
| Accounts Payable | - | 1.07 | 1.14 | 1.06 | 1.76 | 1.5 | Upgrade
|
| Accrued Expenses | - | 0.11 | 0.01 | 0.02 | 0.03 | - | Upgrade
|
| Short-Term Debt | - | 2.47 | 0.4 | 0.81 | - | - | Upgrade
|
| Other Current Liabilities | - | - | 0.5 | 0 | - | - | Upgrade
|
| Total Current Liabilities | - | 3.65 | 2.05 | 1.89 | 1.78 | 1.5 | Upgrade
|
| Total Liabilities | - | 3.65 | 2.05 | 1.89 | 1.78 | 1.5 | Upgrade
|
| Common Stock | - | 30.14 | 30.14 | 30.14 | 30.14 | 30.14 | Upgrade
|
| Retained Earnings | - | -33.46 | -32.09 | -30.01 | -30 | - | Upgrade
|
| Comprehensive Income & Other | - | - | - | - | - | -29.21 | Upgrade
|
| Shareholders' Equity | -7.53 | -3.32 | -1.95 | 0.13 | 0.14 | 0.93 | Upgrade
|
| Total Liabilities & Equity | - | 0.33 | 0.1 | 2.02 | 1.92 | 2.43 | Upgrade
|
| Total Debt | 8.12 | 2.47 | 0.4 | 0.81 | - | - | Upgrade
|
| Net Cash (Debt) | -8.11 | -2.22 | -0.3 | -0.72 | 0 | 0.02 | Upgrade
|
| Net Cash Growth | - | - | - | - | -82.48% | -80.91% | Upgrade
|
| Net Cash Per Share | -1.32 | -0.37 | -0.05 | -0.12 | 0.00 | - | Upgrade
|
| Filing Date Shares Outstanding | 5.9 | 6.03 | 6.03 | 6.03 | 6.07 | - | Upgrade
|
| Total Common Shares Outstanding | 5.9 | 6.03 | 6.03 | 6.03 | 6.07 | - | Upgrade
|
| Working Capital | - | -3.32 | -1.95 | -1.79 | -1.78 | -1.41 | Upgrade
|
| Book Value Per Share | -1.29 | -0.55 | -0.32 | 0.02 | 0.02 | - | Upgrade
|
| Tangible Book Value | -7.53 | -3.32 | -1.95 | 0.13 | 0.14 | 0.93 | Upgrade
|
| Tangible Book Value Per Share | -1.29 | -0.55 | -0.32 | 0.02 | 0.02 | - | Upgrade
|
| Land | - | - | - | 0.17 | 0.17 | - | Upgrade
|
| Buildings | - | - | - | 2.03 | 2.02 | - | Upgrade
|
| Machinery | - | - | - | 2.9 | 2.9 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.